Postmenopausal Women Have Higher Risk for Developing Rheumatoid Arthritis
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- Postmenopausal women, particularly those who experience early menopause, may have a higher risk for developing rheumatoid arthritis (RA), according to a review published online Sept. 30 in BMC Rheumatology.
Negin Namavari, M.D., from the School of Medicine at Peymaniye Hospital and the Jahrom University of Medical Science in Iran, and colleagues conducted a systematic literature review and meta-analysis to assess the association between menopause and RA. Eleven studies were included in the meta-analysis.
The researchers found that postmenopausal women had a higher risk for developing RA versus premenopausal women (odds ratio, 1.35). Women who experienced early menopause (before 45 years of age) showed significantly higher odds of developing RA than those who underwent menopause at a normal age (odds ratio, 2.97).
"These findings underscore the importance of menopausal status as a potential risk factor for RA, with the substantial increase in RA risk associated with early menopause warranting particular attention from both clinicians and researchers," the authors write. "Our results suggest several avenues for future research, including investigation into the biological mechanisms underlying the association between menopause and RA risk, development of targeted preventive strategies for postmenopausal women (especially those who experience early menopause), and exploration of potential interventions to mitigate RA risk in these higher-risk groups."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Increasing Sit-to-Stand Transitions Lowers BP in Postmenopausal Women
FRIDAY, Aug. 8, 2025 -- Changing sedentary behaviors is feasible for postmenopausal women with overweight and obesity, and increasing sit-to-stand transitions (STSTs) is...
Stopping Menopausal Hormone Therapy May Temporarily Increase Fracture Risk
WEDNESDAY, July 30, 2025 -- Stopping menopausal hormone therapy initially leads to several years of elevated fracture risk; however, this risk then decreases, first becoming...
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.